Patients with specific genetic profiles may experience more pronounced fatigue at standard doses, helping PlexusDx recommend personalized starting doses that minimize this risk
This data empowers you and your provider to make evidence-based decisions aligned with your unique genetic blueprint rather than relying on trial-and-error approaches
Its obtained by eligible candidates through prescription
Insulin Secretion : GLP-1 drugs enhance insulin secretion in response to meals, improving blood sugar control and reducing the risk of diabetes, which is often associated with obesity
Quercetin nanoparticle ameliorates lipopolysaccharide-triggered renal inflammatory impairment by regulation of Sirt1/NF-KB pathway
October 24th, 2025: New Study Links Ozempic to Potential Risk of Vision Loss A new study has identified a possible association between Ozempic and non-arteritic anterior ischemic optic neuropathy (NAION), a rare eye condition that can cause sudden and permanent vision loss